Kansai Medical University Hospital Administers First Patient Dose of DS1025 in Global Phase 1 Clinical Trial Sponsored by Daiichi Sankyo
First patient worldwide dosed with investigational DS1025, a potential first-in-class CD25 directed antibody drug conjugate being evaluated in patients wit